pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

5,256 catalysts · 5,256 phase readout · 2,300 8k filing · 343 pdufa · 256 earnings · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 0 catalysts2026-07-29: 0 catalysts2026-07-30: 0 catalysts2026-07-31: 5 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 13 catalysts2026-08-05: 16 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 1 catalyst2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 1 catalyst2026-10-22: 2 catalysts2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: drug expiry×type: phase readout×clear all
type
  • phase readout5,256
  • 8k filing2,300
  • pdufa343
  • earnings256
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›RECRUITINGphase readoutNCT07107022: Study to Collect Real-world Performance and Safety Data on Penumbra System® in Population With Acute Ischemic Stroke (AIS).

Sponsor: Penumbra Inc.. Phase: . Conditions: Acute Ischemic Stroke (AIS)

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07563829: NPX372, a B7-H7:CD3 Bispecific Antibody, in Selected Solid Tumor Malignancies

Sponsor: NextPoint Therapeutics, Inc.. Phase: PHASE1. Conditions: Metastatic Malignant Neoplasm

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07609602: The Psychological Effects of Miscarriage Prediction Score: A Prospective Study

Sponsor: King's College Hospital NHS Trust. Phase: NA. Conditions: Early Pregnancy Bleeding

full page →ctgov ↗
›RECRUITINGphase readoutNCT06935591: Artificial Intelligence Mapping and Ablation of Non-Pulmonary Vein Electrical Drivers of AF Study

Sponsor: Vektor Medical. Phase: NA. Conditions: Atrial Fibrillation (AF)

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07237191: Geriatric Distal Femur

Sponsor: Wake Forest University Health Sciences. Phase: NA. Conditions: Articular Fractures

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03212274: Olaparib in Treating Patients With Advanced Glioma, Cholangiocarcinoma, or Solid Tumors With IDH1 or IDH2 Mutations

Sponsor: National Cancer Institute (NCI). Phase: PHASE2. Conditions: Advanced Malignant Solid Neoplasm, Glioblastoma, Recurrent Cholangiocarcinoma, Recurrent Glioma, Recurrent Malignant Solid Neoplasm, WHO Grade 2 Glioma, WHO Grade 3 Glioma

full page →ctgov ↗
›COMPLETEDphase readoutNCT04221750: Diet and Exercise Plus Metformin to Treat Frailty in Obese Seniors

Sponsor: VA Office of Research and Development. Phase: PHASE3. Conditions: Frailty, Sarcopenic Obesity, Aging

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT07395518: A Randomized Controlled Trial Comparing the Incidence of Surgical Site Infections in Cesarean Section With and Without Subcutaneous Drain Placement at Queen Savang Vadhana Memorial Hospital

Sponsor: Queen Savang Vadhana Memorial Hospital, Thailand. Phase: NA. Conditions: Surgical Site Infection (SSI)

full page →ctgov ↗
›RECRUITINGphase readoutNCT07333118: A Clinical Study to Evaluate the Safety and Efficacy of GT801 Injection in the Treatment of Moderate-to-Severe Refractory Autoimmune Diseases

Sponsor: Grit Biotechnology. Phase: EARLY_PHASE1. Conditions: Moderate to Severe Refractory Autoimmune Disease

full page →ctgov ↗
›RECRUITINGphase readoutNCT02926690: Safety Study of MELK Inhibitor to Treat Patients With Advanced Breast Cancer and Triple Negative Breast Cancer

Sponsor: OncoTherapy Science, Inc.. Phase: PHASE1. Conditions: Relapsed/Refractory Locally Advanced or Metastatic Breast Cancer and Triple Negative Breast Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT07469397: Preliminary Exploration of Factors Affecting Complete Hemostasis and Supine Time After Removal of Femoral Arterial Sheath in ICU Patients

Sponsor: National Taiwan University Hospital. Phase: . Conditions: Removal of Femoral Arterial Sheath in ICU Patients, Complete Hemostasis, Coronary Artery Disease, Percutaneous Coronary Intervention, Transcatheter Aortic Valve Implantation (TAVI)

full page →ctgov ↗
›TERMINATEDphase readoutNCT04550897: A Phase I/II Study With BM7PE Immunotoxin in Colorectal Cancer Patients

Sponsor: Oslo University Hospital. Phase: PHASE1. Conditions: Colorectal Cancer Metastatic

full page →ctgov ↗
›RECRUITINGphase readoutNCT06646497: Indication of HSCT in Patients With Refractory/Relapse AA After First-line Standard Immunosuppressive Therapy Aged More Than 40 Years

Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: PHASE2. Conditions: Aplastic Anemia

full page →ctgov ↗
›RECRUITINGphase readoutNCT07423013: Evaluating the Efficacy and Safety of Teprotumumab N01 in Patients With Thyroid Eye Disease.

Sponsor: Peking University Third Hospital. Phase: NA. Conditions: Thyroid Eye Disease

full page →ctgov ↗
›RECRUITINGphase readoutNCT07454460: AYA-PeerConnect: A Communication Coaching Intervention for Adolescent/Young Adult Cancer Survivors (AYACS)

Sponsor: Milton S. Hershey Medical Center. Phase: NA. Conditions: Communication, Anxiety, Depression, Social Isolation

full page →ctgov ↗
›RECRUITINGphase readoutNCT03467360: Phase I Trial of CArbonic Anhydrase Inhibition in Combination With Radiochemotherapy or Radioimmunotherapy in Small Cell Lung Carcinoma

Sponsor: Centre Antoine Lacassagne. Phase: PHASE1. Conditions: Small Cell Lung Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT06830720: A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase Inhibitor for Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer at High Risk of Recurrence

Sponsor: Novartis Pharmaceuticals. Phase: . Conditions: Breast Neoplasms

full page →ctgov ↗
›COMPLETEDphase readoutNCT06612320: Refusal to Participate in a Randomized Trial Involving Pregnancy and Childbirth: Factors Associated With Refusal and Reasons for Refusal and Acceptance

Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: . Conditions: Pregnancy Related

full page →ctgov ↗
›RECRUITINGphase readoutNCT06032923: Double-blind Placebo Controlled Study to Evaluate the Effect of NAD+ Boosting With Nicotinamide Riboside on Immunometabolism and Immunity in Systemic Lupus Erythematosus

Sponsor: National Heart, Lung, and Blood Institute (NHLBI). Phase: PHASE1. Conditions: Systemic Lupus Erythematosus (Sle)

full page →ctgov ↗
›RECRUITINGphase readoutNCT03270059: Gadolinium and Ferumoxytol MRI in Diagnosing Patients With Abnormalities in the Central Nervous System

Sponsor: OHSU Knight Cancer Institute. Phase: PHASE2. Conditions: Central Nervous System Neoplasm, Cranial Nerve Disorder, Metastatic Malignant Neoplasm in the Brain

full page →ctgov ↗
›TERMINATEDphase readoutNCT05644496: ZYNRELEF for Pain Management in Total Knee Arthroplasty

Sponsor: Baptist Health South Florida. Phase: PHASE4. Conditions: Post Operative Pain, Osteoarthritis, Knee

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05556096: Safety and Efficacy of ALXN1720 in Adults With Generalized Myasthenia Gravis

Sponsor: Alexion Pharmaceuticals, Inc.. Phase: PHASE3. Conditions: Generalized Myasthenia Gravis

full page →ctgov ↗
›COMPLETEDphase readoutNCT06207396: Characteristics of Spiking in Ghent: a Multicentric Prospective Observational Study..

Sponsor: University Hospital, Ghent. Phase: . Conditions: Intoxication, Unintended Ingestion of Product

full page →ctgov ↗
›COMPLETEDphase readoutNCT05966662: Shockwave C2+ 2Hz Coronary IVL Catheter in Calcified Coronary Arteries (Disrupt CAD DUO)

Sponsor: Shockwave Medical, Inc.. Phase: NA. Conditions: Coronary Artery Disease, Myocardial Infarction

full page →ctgov ↗
›RECRUITINGphase readoutNCT07403162: Cuevas Medek Exercises to Improve Postural Control and Balance in Children With Spastic Cerebral Palsy

Sponsor: Riphah International University. Phase: NA. Conditions: Spastic Cerebral Palsy (sCP)

full page →ctgov ↗
›RECRUITINGphase readoutNCT03747146: Enhanced Recovery After Surgery (ERAS) Total Knee Replacement (TKR) With a Transitional Pain Service

Sponsor: Hospital for Special Surgery, New York. Phase: NA. Conditions: Anesthesia

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04924088: Medical-legal Partnerships to Prevent Evictions and Homelessness Among Veterans

Sponsor: VA Office of Research and Development. Phase: NA. Conditions: Homelessness, Mental Health

full page →ctgov ↗
›COMPLETEDphase readoutNCT06971588: The Role of Music in Enhancing Attention During Visual Field Exams for Pediatric Glaucoma Patients

Sponsor: Johns Hopkins University. Phase: NA. Conditions: Glaucoma

full page →ctgov ↗
›COMPLETEDphase readoutNCT07506603: Kenya Preschool Study

Sponsor: Yale University. Phase: NA. Conditions: Early Education, Early Childhood Development

full page →ctgov ↗
›RECRUITINGphase readoutNCT06242327: An Outcome Analysis of Primary Membranous Nephropathy

Sponsor: Mario Negri Institute for Pharmacological Research. Phase: . Conditions: Membranous Nephropathy

full page →ctgov ↗
›RECRUITINGphase readoutNCT07381127: INTUPRO in the Treatment of Benign Prostatic Hyperplasia-Related Symptoms

Sponsor: inTumo Therapeutics, Inc.. Phase: NA. Conditions: BPH (Benign Prostatic Hyperplasia), BPH, BPH With Other Lower Urinary Tract Symptoms

full page →ctgov ↗
›RECRUITINGphase readoutNCT04436042: MyHand 2: An Active Hand Orthosis for Stroke Patients

Sponsor: Columbia University. Phase: NA. Conditions: Stroke, Hemiparesis

full page →ctgov ↗
›COMPLETEDphase readoutNCT04887142: Predictors of Disease Severity in COVID-19 Patients

Sponsor: Zeljko Mijailovic. Phase: . Conditions: COVID-19

full page →ctgov ↗
›RECRUITINGphase readoutNCT06111586: FrexalimAB in Preservation of Endogenous insULIN Secretion Compared to Placebo in adUlts and Adolescents on Top of inSulin Therapy (FABULINUS)

Sponsor: Sanofi. Phase: PHASE2. Conditions: Type 1 Diabetes Mellitus

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT06481670: Carbohydrate Fluids and Post Operative Nausea and Vomiting

Sponsor: Boston Medical Center. Phase: NA. Conditions: Nausea, Postoperative, Vomiting, Postoperative

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06560970: A Technology-based Psychosocial Intervention to Support Social Engagement and Well-being in Older Adults With HIV

Sponsor: Weill Medical College of Cornell University. Phase: NA. Conditions: HIV Diagnosis

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07521670: Sacituzumab Tirumotecan in Recurrent/Metastatic Adenoid Cystic Carcinoma and Papillary Thyroid Carcinoma (STRAP)

Sponsor: National Cancer Centre, Singapore. Phase: PHASE2. Conditions: Recurrent Adenoid Cystic Carcinoma, Adenoid Cystic Carcinoma Metastatic, Papillary Thyroid Carcinoma

full page →ctgov ↗
›RECRUITINGphase readoutNCT07590973: Online Evaluation of the Diagnostic Accuracy of BlinkLab's Digital Assessments for Autism

Sponsor: Blinklab Limited. Phase: . Conditions: Autism, Autism Spectrum Disorder, Autism Spectrum Disorder (ASD), Neurodevelopmental Conditions

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04241341: Does Immediate Lymphatic Reconstruction Decrease the Risk of Lymphedema After Axillary Lymph Node Dissection

Sponsor: Memorial Sloan Kettering Cancer Center. Phase: PHASE3. Conditions: Breast Cancer Lymphedema

full page →ctgov ↗
›RECRUITINGphase readoutNCT06290505: A Trial of Palliative Chemotherapy, Radiation and Immune Treatment for Oesophageal Cancer: PALEO Study

Sponsor: Australasian Gastro-Intestinal Trials Group. Phase: PHASE2. Conditions: Esophageal Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT05354622: Hereditary Spastic Paraplegia Genomic Sequencing Initiative (HSPseq)

Sponsor: Boston Children's Hospital. Phase: . Conditions: Hereditary Spastic Paraplegia, Neurodegenerative Diseases, Pediatric Disorder, Spasticity, Muscle, Motor Neuron Disease, Movement Disorders

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07246629: Lumbar Drain With Intrathecal Nicardipine in Aneurysmal Subarachnoid Hemorrhage

Sponsor: Wake Forest University Health Sciences. Phase: PHASE4. Conditions: Subarachnoid Hemorrhage

full page →ctgov ↗
›RECRUITINGphase readoutNCT02993029: 99Tc-MDP Treatment for Knee Osteoarthritis

Sponsor: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine. Phase: NA. Conditions: Treatment Outcome

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT01628029: Cognitive Behavioral Therapy and Multimodal Therapy in Treating Sleep Disturbance in Patients With Cancer

Sponsor: M.D. Anderson Cancer Center. Phase: PHASE2. Conditions: Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm, Sleep Disorder

full page →ctgov ↗
›RECRUITINGphase readoutNCT07539831: Effects of Menstrual Cycle on Optic Nerve Sheath Diameter in Patients Undergoing Laparoscopic Gynecologic Surgery

Sponsor: Konya City Hospital. Phase: . Conditions: Menstrual Cycle, Optic Nerve Sheath Diameter, Postoperative Nausea and Vomiting

full page →ctgov ↗
›RECRUITINGphase readoutNCT02936791: Early PKD Observational Cohort Study

Sponsor: University of Kansas Medical Center. Phase: . Conditions: Polycystic Kidney Disease

full page →ctgov ↗
›RECRUITINGphase readoutNCT06212791: EXercise Cardiac Magnetic Resonance Assessment of Left Atrial Mechanics Following Ablation

Sponsor: Virginia Commonwealth University. Phase: . Conditions: Paroxysmal Atrial Fibrillation

full page →ctgov ↗
›COMPLETEDphase readoutNCT06540118: Food Is Medicine for Patients With Heart Failure

Sponsor: University of California, San Diego. Phase: NA. Conditions: Heart Failure, Heart Failure,Congestive, Heart Diseases

full page →ctgov ↗
›RECRUITINGphase readoutNCT07310290: Study to Assess the Real-World Effectiveness of Ubrogepant in Adult Participants When Treating During the Prodrome Phase of Migraine Attacks

Sponsor: AbbVie. Phase: . Conditions: Migraine

full page →ctgov ↗
›RECRUITINGphase readoutNCT07133490: INTERACT Stomach-II

Sponsor: Erasmus Medical Center. Phase: PHASE2. Conditions: Peritoneal Metastases From Gastric Cancer

full page →ctgov ↗
← prev
page 47 of 106
next →